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ABSTRACT 
Immunization by an antigen-encoding DNA (DNA vaccines) has shown promising results in 
rendering protection against some bacterial and viral diseases in fish. However, some studies 
showed that DNA vaccines induce variable levels of protection compared with the other types of 
vaccination. These results are driving the research interest against these infectious diseases to 
improve the efficacy of DNA vaccines. Recently, chimeric antigens in DNA vaccines have been 
reported to increase the protection against certain diseases by enhancing specific antibody 
responses. In this study, we assessed the use of a chimeric DNA vaccine by using lysosome-
associated membrane protein-1 (LAMP1) fused with the major capsule protein (MCP) from red 
seabream iridovirus. First, Japanese flounder (Paralichthys olivaceus) LAMP-1 (jfLAMP1) gene 
was cloned and characterized through tissue distribution and expression analysis. The ORF for 
jfLAMP1 gene has a length of 1248 bp that encodes for 415 aa (about 44 KDa) and shows highly 
conserved transmembrane and cytoplasmic domains as those of higher vertebrates. Then, jfLAMP1 
was used as a carrier of MCP gene by replacing the intra-lysosomal domain, and subsequent 
inserting into an expression vector, pCI-neo. In the vaccination trial, juveniles of Japanese flounder 
were distributed into four groups: pCMCP (MCP in pCI-neo vector), pCLAMP1-MCP (chimeric 
DNA of jfLAMP1 and MCP in pCI-neo), rMCP (recombinant MCP) and pCI-neo (empty vector as 
a control). At 30 days post vaccination, blood samples were taken and the serum antibody titers 
were measured by ELISA. The 3 vaccinated groups showed higher antibody titers than pCI-neo 
group. The pCLAMP1-MCP vaccinated fish showed antibody levels significantly higher than 
pCMCP (p<0.05). These results will serve as a basis for the use of LAMP1-chimeric DNA vaccines 
to increase the immune response against certain infectious diseases, for which conventional DNA 
vaccines show marginal efficacy. 
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